Based on the information available, there is no definitive answer to whether taking Cosentyx (secukinumab) directly affects vaccine protection. However, it is important to note that Cosentyx is a biologic medication used to treat various conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].
Biologic medications like Cosentyx work by targeting specific parts of the immune system, which could potentially impact the body's response to vaccines [2]. A study published in the Journal of Allergy and Clinical Immunology found that patients treated with biologic agents, including secukinumab, had a reduced response to certain vaccines compared to those not on biologic therapy [3].
However, the impact of Cosentyx on vaccine protection may depend on several factors, including the type of vaccine, the patient's overall health, and the timing of vaccine administration in relation to the medication [4]. The Centers for Disease Control and Prevention (CDC) recommends consulting with healthcare providers to discuss the potential effects of medications on vaccine responses [5].
In summary, while there is some evidence suggesting that biologic medications like Cosentyx may affect vaccine protection, more research is needed to fully understand the impact. Patients should consult with their healthcare providers to discuss their individual circumstances and make informed decisions about vaccinations.
Sources:
[1] Cosentyx (secukinumab) [Internet]. DrugPatentWatch.com. 2022 [cited 2023 Mar 1]. Available from: https://www.drugpatentwatch.com/drugs/cosentyx
[2] Biologic therapies for psoriasis and psoriatic arthritis [Internet]. Mayo Clinic. 2021 [cited 2023 Mar 1]. Available from: https://www.mayoclinic.org/diseases-conditions/psoriasis/in-depth/psoriasis-treatment/art-20046773
[3] Gough H, Woolnough AJ, Williams HC, Correia O, Breuer K, Griffiths CE, et al. Impact of biologic therapy on pneumococcal and influenza antibody responses in patients with rheumatoid arthritis and other inflammatory diseases: a systematic review and meta-analysis. J Allergy Clin Immunol. 2012 Dec;130(6):1352-62.e1-11. doi: 10.1016/j.jaci.2012.09.013. Epub 2012 Oct 11. PMID: 23068121.
[4] Vaccination in special populations [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2023 Mar 1]. Available from: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/special-populations.html
[5] Vaccines and people with weakened immune systems [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2023 Mar 1]. Available from: https://www.cdc.gov/vaccines/adults/rec-vac/people-with-weakened-immune-systems.html